New Novavax R&D Leader Raises Questions On Valuation Gap And Outlook [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
Novavax appointed Dr. Robert Walker as Executive Vice President and Head of Research & Development. The appointment reshapes leadership of the NasdaqGS:NVAX R&D organization. Dr. Walker has prior experience influencing Novavax's R&D strategy. For investors watching NasdaqGS:NVAX, this leadership move comes at a time when sentiment around the stock has been mixed. The shares most recently closed at $8.09, with a 7 day return of a 16.8% decline and a 30 day return of a 20.2% decline, while the 1 year return stands at 26.2%. Over a 5 year period, the stock shows a 95.4% decline, highlighting how sensitive the name has been for long term holders. Bringing R&D under Dr. Walker's direction could influence how Novavax prioritizes its scientific programs and allocates research resources. Readers may want to track how future pipeline disclosures, clinical updates, and partnerships line up with this leadership shift, as those developments often shape sentiment toward biotechnology comp
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- 2 Growth Stocks Set to Flourishand 1 We Question [Yahoo! Finance]Yahoo! Finance
- 3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next [Yahoo! Finance]Yahoo! Finance
- Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development [Yahoo! Finance]Yahoo! Finance
- Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & DevelopmentPR Newswire
- 2 Healthcare Stocks to Target This Week and 1 That Underwhelm [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/26/26 - Beat
NVAX
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/12/26 - Form 4
- 3/9/26 - Form 4
- NVAX's page on the SEC website